Clinical trials
Carcinoma, Renal Cell trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 5 |
| 2019 | 7 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Active, not recruiting | 11 |
| Terminated | 9 |
| Recruiting | 4 |
| Approved for marketing | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 12 |
| Merck Sharp & Dohme LLC | 6 |
| Pfizer | 6 |
| Hoffmann-La Roche | 4 |
| Exelixis | 2 |
| Incyte Corporation | 2 |
| National Taiwan University Hospital | 2 |
| Arcus Biosciences, Inc. | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 51 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Melanoma | 10 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Colorectal Neoplasms | 7 |
| Esophageal Neoplasms | 6 |
| Kidney Neoplasms | 6 |
| Ovarian Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Carcinoma | 5 |
Trials
Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.